| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2409 | 2018 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2043* | 2020 |
| Age-related mutations associated with clonal hematopoietic expansion and malignancies M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ... Nature medicine 20 (12), 1472-1478, 2014 | 2042 | 2014 |
| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1674 | 2016 |
| Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017 | 917 | 2017 |
| Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma G Ledergor, A Weiner, M Zada, SY Wang, YC Cohen, ME Gatt, N Snir, ... Nature medicine 24 (12), 1867-1876, 2018 | 243 | 2018 |
| Timing the initiation of multiple myeloma EH Rustad, V Yellapantula, D Leongamornlert, N Bolli, G Ledergor, ... Nature communications 11 (1), 1917, 2020 | 156 | 2020 |
| Systematic discovery of complex insertions and deletions in human cancers K Ye, J Wang, R Jayasinghe, EW Lameijer, JF McMichael, J Ning, ... Nature medicine 22 (1), 97-104, 2016 | 123 | 2016 |
| Revealing the impact of structural variants in multiple myeloma EH Rustad, VD Yellapantula, D Glodzik, KH Maclachlan, B Diamond, ... Blood cancer discovery 1 (3), 258-273, 2020 | 112 | 2020 |
| Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities B Oben, G Froyen, KH Maclachlan, D Leongamornlert, F Abascal, ... Nature communications 12 (1), 1861, 2021 | 102 | 2021 |
| Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma: the … O Landgren, M Hultcrantz, B Diamond, AM Lesokhin, S Mailankody, ... JAMA oncology 7 (6), 862-868, 2021 | 99 | 2021 |
| Accelerated single cell seeding in relapsed multiple myeloma Nature Communiations 3617 (https://doi.org/10.1038/s41467-020-17459), 2020 | 57* | 2020 |
| Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma V Yellapantula, M Hultcrantz, EH Rustad, E Wasserman, D Londono, ... Blood cancer journal 9 (12), 101, 2019 | 56 | 2019 |
| Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients D Kazandjian, E Hill, M Hultcrantz, EH Rustad, V Yellapantula, T Akhlaghi, ... Blood Cancer Journal 9 (2), 15, 2019 | 52 | 2019 |
| Group MCW MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cancer Genome Atlas Research N, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart …, 2018 | 47 | 2018 |
| Interim analysis of the mmrf commpass trial, a longitudinal study in multiple myeloma relating clinical outcomes to genomic and immunophenotypic profiles JJ Keats, DW Craig, W Liang, Y Venkata, A Kurdoglu, J Aldrich, D Auclair, ... Blood, The Journal of the American Society of Hematology 122 (21), 532-532, 2013 | 47 | 2013 |
| Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples MH Bailey, WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, ... Nature communications 11 (1), 4748, 2020 | 45 | 2020 |
| Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma F Maura, EH Rustad, V Yellapantula, M Łuksza, D Hoyos, KH Maclachlan, ... Leukemia 34 (5), 1476-1480, 2020 | 45 | 2020 |
| Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: a … O Landgren, M Hultcrantz, AM Lesokhin, S Mailankody, H Hassoun, ... Blood 134, 862, 2019 | 41 | 2019 |
| Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma KH Maclachlan, EH Rustad, A Derkach, B Zheng-Lin, V Yellapantula, ... Nature communications 12 (1), 5172, 2021 | 39 | 2021 |
